Issue |
J Oral Med Oral Surg
Volume 24, Number 1, January 2018
|
|
---|---|---|
Page(s) | 6 - 10 | |
Section | Article original / Original article | |
DOI | https://doi.org/10.1051/mbcb/2017027 | |
Published online | 25 May 2018 |
Original Article
Maxillary ameloblastoma: results of the treatment in 11 patients
1
Department of Stomatology and Maxillofacial Surgery,
CHU Souro Sanou, Burkina Faso
2
Department of Stomatology and Maxillofacial Surgery, CHU Yalgado Ouédraogo,
Ouagadougou, Burkina Faso
* Correspondence: rbeogo@yahoo.fr
Received:
8
June
2017
Accepted:
14
November
2017
Introduction: Surgery of maxilla ameloblastoma is mutilating and the tumor propensity for recurrence high. Patients and Methods: The oral and visual functions, facial morphology and tumor recurrence in 11 patients after maxillary ameloblastoma surgery are retrospectively reviewed. Results: Facial morphology was satisfactory in 7 patients who had all tumor removal by a type 1 or 2A maxillectomy and surgical wound closure. Out of these patients, 4 who had dental rehabilitation by conventional prosthesis presented satisfactory mastication. Four patients subjected to the tumor removal by a type 3 maxillectomy had all facial asymmetry. Out of these, 1 patient who did not have the orbital floor defect repair presented diplopia and enophtalmos, 2 patients subjected to the palate defect repair by a prosthetic obturator or oral mucosa had elocution impairment. The tumor recurrence occurred in 2 patients after tumor enucleation and in 1 patient after radical surgery out of 8 patients who had a postoperative follow-up. Discussion: In ameloblastoma surgery, achieving both the tumor recurrence prevention and a satisfactory facial reconstruction is challenging. Conclusion: Avoiding the tumor recurrence should be the major goal when patient post-surgical follow-up cannot be guaranteed.
Key words: ameloblastoma / maxillary ameloblastoma / ameloblastoma surgery / ameloblastoma recurrence
© The authors, 2018
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.